Brookfield Business Partners (TSE:BBU.UN) Reaches New 52-Week High at $51.08

Share on StockTwits

Shares of Brookfield Business Partners LP (TSE:BBU.UN) reached a new 52-week high on Monday . The stock traded as high as C$51.08 and last traded at C$51.00, with a volume of 787 shares trading hands. The stock had previously closed at C$50.74.

Separately, BMO Capital Markets set a C$47.00 price target on shares of Brookfield Business Partners and gave the company an “outperform” rating in a research note on Tuesday, June 4th.

The company has a current ratio of 1.15, a quick ratio of 0.82 and a debt-to-equity ratio of 183.26. The company has a market cap of $6.56 billion and a price-to-earnings ratio of -87.86.

ILLEGAL ACTIVITY NOTICE: This article was originally published by Zolmax and is the property of of Zolmax. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://zolmax.com/investing/brookfield-business-partners-tsebbu-un-reaches-new-52-week-high-at-51-08/3116909.html.

About Brookfield Business Partners (TSE:BBU.UN)

Brookfield Business Partners L.P. is a private equity firm specializes in acquisition. The firm typically invests in business services, construction, energy, and industrials sector. It prefers to take majority stake in companies. The firm seeks returns of at least 15% on its investments. Brookfield Business Partners L.P.

Featured Story: Return on Investment (ROI)

Receive News & Ratings for Brookfield Business Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brookfield Business Partners and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Trupanion Inc  Receives Average Recommendation of “Buy” from Analysts
Trupanion Inc Receives Average Recommendation of “Buy” from Analysts
MorphoSys AG  Receives Average Rating of “Hold” from Brokerages
MorphoSys AG Receives Average Rating of “Hold” from Brokerages
Brokerages Anticipate Calix Inc  Will Post Quarterly Sales of $99.95 Million
Brokerages Anticipate Calix Inc Will Post Quarterly Sales of $99.95 Million
Primas  Price Tops $0.0906
Primas Price Tops $0.0906
iShares S&P Mid-Cap 400 Growth ETF   Shares Down 0.2%
iShares S&P Mid-Cap 400 Growth ETF Shares Down 0.2%
Global X China Financials ETF  Trading Up 0.1%
Global X China Financials ETF Trading Up 0.1%


 
© 2006-2019 Zolmax.